Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Diopsys develops new electroretinography test

Diopsys, a medical instrumentation company, has developed a new office-based Nova-Pattern electroretinography (PERG) test.

By utilizing visual evoked potential technology, the test measures the function of the inner retinal cells of the eye, especially in an area of the retina called the macula, which aids optometrists and ophthalmologists to diagnose and monitor vision disorders like glaucoma, macular degeneration and diabetic retinopathy.

Diopsys research director Alberto Gonzalez said the Diopsys NOVA-PERG is a new important addition to the company’s NOVA suite of tests.

"In one sitting, an eye care specialist can objectively measure the function of the patient’s retina while also measuring the function of the entire vision system, from the eye to the visual cortex," Gonzalez added.

"This will help doctors objectively distinguish between retinal and cortical pathway issues."

The company said it is also planning to launch the Nova-PERG test in 2012.